Chemomab Therapeutics CMMB Cash Flow Statement (2017-2026)

NASDAQ CMMB
$1.64 +0.03 (+1.86%)
As of: Sep 30, 2026 · 10:06 AM EDT
Reported Financials

Chemomab Therapeutics Quarterly Cash Flow Statement

Periods 35 quarters
Latest Jun 2026

Chemomab Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-2.97M19.92M-5.10M7.28M-8.08M-8.27M8.71M7.90M-4.08M-3.42M3.87M3.63M3.48M2.96M3.32M2.06M1.74M1.87M1.77M2.17M
Depreciation and Depletion
0.01M0.01M0.01M0.01M0.02M0.01M0.02M0.02M0.02M0.02M
Share-based Compensation
0.44M1.01M0.87M0.76M0.84M0.74M0.48M0.64M0.13M0.24M
Gains from Sales and Divestitures
Asset Writedowns and Impairment
Cash from Operations
-2.58M-2.89M-3.71M-5.70M-5.25M-5.70M-7.19M-7.49M-5.22M-3.72M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.01M0.01M0.01M0.01M0.02M0.01M0.02M0.02M0.02M0.02M
Change in Working Capital
Change in Receivables
Change in Account Payables
0.01M0.85M0.15M-0.05M-0.19M0.44M0.53M0.13M-1.62M-0.21M
Change in Accured Expenses
-0.27M-0.02M0.69M0.46M0.86M0.80M-0.21M-0.66M0.50M0.42M
Other Working Capital Changes
-0.38M-4.20M0.36M-1.85M0.88M0.54M-0.81M1.62M0.16M-0.07M
Investing Activities
Capital Expenditures
-0.34M0.01M-0.04M-0.04M-0.00M0.00M-0.00M
Sales of Property, Plant and Equipment
Cash from Investing Activities
-5.00M-19.58M2.38M1.73M6.07M9.35M14.43M-4.27M3.99M1.72M
Financing Activities
Other financing activities
6.12M3.99M
Change in Capital Stock
Net Equity Issued and Repurchased
0.01M0.04M0.08M0.00M1.55M
Misc.
Cash from Financing Activities
-0.07M-0.08M0.02M0.04M-0.87M1.37M0.00M2.13M
Exchange Rate Effect
Change in Cash
-7.65M-22.56M-1.33M-3.95M0.86M2.78M7.25M-10.39M-1.23M0.14M
Free Cash Flow
-2.58M-2.55M-3.73M-5.66M-5.21M-5.70M-7.19M-7.48M-5.22M-3.72M
Net Cash Flow
-7.65M-22.56M-1.33M-3.95M0.86M2.78M7.25M-10.39M-1.23M0.14M

Chemomab Therapeutics Cash Flow Statement API

Pull Chemomab Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CMMB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY